New multiplex tests and next-gen SAMBA platform previewed in 360Dx

In a wide-ranging interview with Justin Petrone for GenomeWeb's 360Dx, Diagnostics for the Real World CEO and Chairman Dr Helen Lee and COO Craig Wisniewski talk exclusively about DRW's new assays – the SAMBA II SARS-CoV-2/Flu and SAMBA II SARS-CoV-2/RSV multiplex tests – plus the company's plans for the third-generation SAMBA platform, now in development.

Read the full article here (requires subscription to view).

Dr. Helen Lee

Image copyright: DRW

Discover SAMBA II: a game changer
in the fight against Corona >